First-in-human multicenter phase I study of BMS-936561 (MDX-1203), an antibody-drug conjugate targeting CD70

Taofeek K. Owonikoko; Arif Hussain; Walter M. Stadler; David Smith; Harriet M. Kluger; Ana M. Molina; Parul Gulati; Aadhar Shah; Christoph Matthias Ahlers; Pina M. Cardarelli

doi:https://doi.org/10.1007/s00280-015-2909-2

doi.org/10.1007/s00280-015-2909-2

First-in-human multicenter phase I study of BMS-936561 (MDX-1203), an antibody-drug conjugate targeting CD70

,

,

..., Pina M. Cardarelli

17

Cancer Chemotherapy and Pharmacology3.00

Volume: 77, Issue: 1, Pages: 155 - 162

Published: Nov 14, 2015

Abstract

Purpose The study evaluated the safety, tolerability, and pharmacokinetics of BMS-936561, a fully human monoclonal antibody-drug conjugate targeting CD70 cell-surface...

Paper Fields

Paper Details

Title

First-in-human multicenter phase I study of BMS-936561 (MDX-1203), an antibody-drug conjugate targeting CD70

DOI

doi.org/10.1007/s00280-015-2909-2

Published Date

Nov 14, 2015

Journal

Cancer Chemotherapy and Pharmacology

Volume

77

Issue

1

Pages

155 - 162

Citation AnalysisPro

You’ll need to upgrade your plan to Pro

Looking to understand the true influence of a researcher’s work across journals & affiliations?

Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.

Learn more

Notes

History